50/50 Mixture Recombinant Human Insulin（Tonghua Dongbao Pharmaceutical）
50/50混合重组人胰岛素（通化东宝）
Report date: 2022/01/14 13:23:58
Base Information
Drug Name50/50 Mixture Recombinant Human Insulin（Tonghua Dongbao Pharmaceutical）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2008/02/04
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTonghua Dongbao Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTonghua Dongbao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A